연구성과로 돌아가기
2022 연구자 정보 (92 / 1074)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Calleja, Jose Luis (Calleja, JL) |
Hosp U Puerta Hierro, IDIPHIM CIBERehd, Madrid, Spain Hosp U Puerta de Hierro, IDIPHIM CIBERehd, Madrid, Spain |
A-5351-2010 Panero, Jose |
|
[JCR상위 3.8] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B [JCR상위 8.1] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B |
SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY |
gepapath@med.uoa.gr;pindra@empal.com; pindra@empal.com;gepapath@med.uoa.gr; |
||
|
Campbell, Fiona M. (Campbell, FM) |
GSK, Hepatol GI Clin Sci, Stevenage, Herts, England |
|
|
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Chayama, Kazuaki (Chayama, K) |
Hiroshima Univ, Collaborat Res Lab Med Innovat, Hiroshima, Japan Hiroshima Univ, Res Ctr Hepatol & Gastroenterol, Hiroshima, Japan RIKEN Ctr Integrat Med Sci, Yokohama, Japan |
G-2917-2019 chayama, Kazuaki |
0000-0002-5530-5341 Chayama, Kazuaki |
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Cho, Young Youn (Cho, YY) |
Chung Ang Univ Hosp, Internal Med, Seoul, South Korea |
|
|
[JCR상위 3.8] Diagnostic efficacy of Mac-2 binding protein glycosylation isomer for predicting liver fibrosis in patients with metabolic associated fatty liver disease | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | gongori1004@gmail.com; | ||
|
Cremer, Jennifer (Cremer, J) |
GSK, Hepatol GI Clin Sci, Stevenage, Herts, England |
|
|
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Dalekos, George N. (Dalekos, GN) |
Gen Univ Hosp Larissa, Dept Med, Larisa, Greece Gen Univ Hosp Larissa, Res Lab Internal Med, Natl Expertise Ctr Greece Autoimmune Liver Dis, Larisa, Greece Gen Univ Hosp Larissa, Natl Expertise Ctr Greece Autoimmune Liver Dis, Dept Med, Larisa, Greece Gen Univ Hosp Larissa, Natl Expertise Ctr Greece Autoimmune Liver Dis, Res Lab Internal Med, Larisa, Greece |
|
|
[JCR상위 3.8] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B [JCR상위 8.1] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B |
SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY |
gepapath@med.uoa.gr;pindra@empal.com; pindra@empal.com;gepapath@med.uoa.gr; |
||
|
Davies, Matt (Davies, M) |
GSK, Global Safety, Brentford, England |
|
0000-0001-7545-8460 Davies, Matt |
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Duan, Zhongping (Duan, ZP) |
Capital Med Univ, Beijing Youan Hosp, Artif Liver Ctr, Beijing, Peoples R China |
|
|
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Elston, Robert (Elston, R) |
GSK, Hepatol GI Clin Sci, Stevenage, Herts, England |
|
|
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Goulis, John (Goulis, J) |
Aristotle Univ Thessaloniki, Gen Hosp Thessaloniki Hippokratio, Dept Internal Med 4, Med Sch, Thessaloniki, Greece Ristotle Univ Thessaloniki, Gen Hosp Thessaloniki Hippokratio, Dept Internal Med, Med Sch, Thessaloniki, Greece |
|
|
[JCR상위 3.8] An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B [JCR상위 8.1] Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B |
SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY |
gepapath@med.uoa.gr;pindra@empal.com; pindra@empal.com;gepapath@med.uoa.gr; |
||
|
Han, Kelong (Han, KL) |
GSK, Clin Pharmacol Modeling & Simulat, Collegeville, PA USA |
J-5233-2014 Han, Kelong |
0000-0001-8010-9898 Han, Kelong |
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Heo, Hyojin (Heo, H) |
제1저자 | Kyungpook Natl Univ, Sch Dent, Dept Prevent Dent, 2177 Dalgubeol Daero, Daegu 41940, South Korea |
|
0000-0002-5403-7795 Hur, Hyojin |
[JCR상위 3.8] Supplemental or dietary intake of omega-3 fatty acids for the treatment of periodontitis: A meta-analysis | SCIE | 3.8 | DENTISTRY, ORAL SURGERY & MEDICINE | cyh1001@knu.ac.kr; | |
|
Heo, Nae-Yun (Heo, NY) |
Inje Univ, Haeundae Paik Hosp, Coll Med, Gimhae, South Korea |
LUY-9667-2024 Heo, Nae-Yun |
|
[JCR상위 3.8] Noninvasive prediction of hepatocellular carcinoma development after oral antiviral therapy in patients with chronic hepatitis C: a multicenter study | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | psyoung0419@gmail.com; | ||
|
Hou, Jinlin (Hou, JL) |
Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Peoples R China |
|
|
[JCR상위 3.8] Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy | SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY | mfyuen@hku.hk; | ||
|
Hwang, Jae-Seok (Hwang, JS) |
Keimyung Univ, Sch Med, Internal Med, Daegu, South Korea |
|
|
[JCR상위 3.8] Myosteatosis and excessive visceral adipose tissue as prognostic factors in patients with hepatocellular carcinoma treated with sorafenib [JCR상위 3.8] Noninvasive prediction of hepatocellular carcinoma development after oral antiviral therapy in patients with chronic hepatitis C: a multicenter study |
SCIE | 3.8 | GASTROENTEROLOGY & HEPATOLOGY |
kmggood111@naver.com; psyoung0419@gmail.com; |
페이지 이동: